MedTrace Logo

Prospective Study of the sensiTVT

NCT03603535 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 35

Last updated 2025-02-28

No results posted yet for this study

Summary

sensiTVT is a relatively new tape. The aim of this study is to analyze the objective and subjective outcome at one year follow-up.

Conditions

  • Stress Urinary Incontinence

Interventions

DEVICE

sensiTVT

The study is designed as a prospective single arm study. All women with an indication for suburethral tape placement for therapy of SUI and meeting the inclusion criteria will be offered study participation to record the objective outcome after one year.

Sponsors & Collaborators

  • Medical University Innsbruck

    collaborator OTHER

  • Medical University of Graz

    lead OTHER

Principal Investigators

  • Daniela Gold (prev. Ulrich), MD PhD · Universitätsklinik für Frauenheilkunde und Geburtshilfe

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-10-08
Primary Completion
2023-09-30
Completion
2023-09-30

Countries

  • Austria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03603535 on ClinicalTrials.gov